Royal Bank Of Canada Miromatrix Medical Inc. Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.92 - $2.03 $12,255 - $27,041	13,321 Added 666.05%	15,321 $26,000
Q4 2022 Feb 14, 2023	SELL	$2.5 - $4.44 $177 - $315	-71 Reduced 3.43%	2,000 $5,000
Q3 2022 Nov 14, 2022	BUY	$2.27 - $4.86 $161 - $345	71 Added 3.55%	2,071 $9,000
Q1 2022 May 16, 2022	SELL	$2.03 - $4.73 $16,239 - $37,840	-8,000 Reduced 80.0%	2,000 $8,000
Q4 2021 Feb 14, 2022	BUY	$4.45 - $9.4 $35,600 - $75,200	8,000 Added 400.0%	10,000 $47,000
Q3 2021 Nov 15, 2021	BUY	$6.6 - $12.75 $13,200 - $25,500	2,000 New	2,000 $14,000

Ticker MIRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,899,200
Description
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified huma...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.